Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Glycopyrronium Bromide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 23 USDMF, 9 CEP/COS, 2 JDMF, 6 EU WC, 6 KDMF, 22 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

FINISHED DOSAGE FORMULATIONS

149 FDF Dossiers, 87 FDA Orange Book, 22 Europe, 13 Canada, 2 Australia, 7 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, INJECTABLE;INJECTION - 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 15.6MCG/INH, POWDER;INHALATION - 15.6MCG/INH;27.5MCG/INH, SOLUTION;INHALATION - 25MCG/ML, TABLET, ORALLY DISINTEGRATING;ORAL - 1.7MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 6 SPI Pharma, 1 DKSH, 4 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 8 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 6 DFE Pharma, 3 Finar, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 27 Kerry, 12 Microlex e.U, 1 Nippon Fine Chemical, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 26 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 22 Direct Compression, 17 Disintegrants & Superdisintegrants, 16 Granulation, 16 Parenteral, 14 Thickeners and Stabilizers, 14 Co-Processed Excipients, 14 Film Formers & Plasticizers, 11 Taste Masking, 11 Lubricants & Glidants, 10 Solubilizers, 10 Coating Systems & Additives, 9 Controlled & Modified Release, 7 Topical, 7 Chewable & Orodispersible Aids, 3 Emulsifying Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Dry Powder Inhalation

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 113 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 27 Regulatory FDF Prices, 25 Annual Reports

MARKET PLACE

23 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

31 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 11 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/03/2025	Inke S.A	Spain	Inke, S.A. Castellbisbal ES	R1-CEP 2017-182 - Rev 00	Glycopyrronium bromide, Micronised, non-micronised	2023-08-17	Valid	Chemical		1783
28/03/2025	Seqens	France	PCAS Ecully FR	R1-CEP 2012-129 - Rev 01	Glycopyrronium bromide	2020-07-30	Valid	Chemical		1783

Glycopyrronium Bromide

Glycopyrronium Bromide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

23 USDMF

9 CEP/COS

2 JDMF

6 EU WC

6 KDMF

22 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

FINISHED DOSAGE FORMULATIONS

149 FDF Dossiers

87 FDA Orange Book

22 Europe

13 Canada

2 Australia

7 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG

TABLET;ORAL - 2MG

INJECTABLE;INJECTION - 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INHALATION - 15.6MCG/INH

POWDER;INHALATION - 15.6MCG/INH;27.5MCG/INH

SOLUTION;INHALATION - 25MCG/ML

TABLET, ORALLY DISINTEGRATING;ORAL - 1.7MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

6 SPI Pharma

1 DKSH

4 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

8 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

6 DFE Pharma

3 Finar

5 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

27 Kerry

12 Microlex e.U

1 Nippon Fine Chemical

1 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

26 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

1 Ulanqab Kema New Material

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders

22 Direct Compression

17 Disintegrants & Superdisintegrants

16 Granulation

16 Parenteral

14 Thickeners and Stabilizers

14 Co-Processed Excipients

14 Film Formers & Plasticizers

11 Taste Masking

11 Lubricants & Glidants

10 Solubilizers

INJECTABLE;INJECTION - 0.2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons